Will the Phase 3 trial "Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction" reach primary completion on or before Mar 27, 2029?

Resolves Yes if ClinicalTrials.gov record NCT07084519 (Cancer Institute and Hospital, Chinese Academy of Medical Sciences) shows an actual primary completion date on or before Mar 27, 2029. Registered date at generation: Mar 27, 2029.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Mar 27, 2029, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.